Application 078414
- Type
- ANDA
- Sponsor
- OXFORD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
| 002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 10MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078414-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2010-04-07 | |
| A078414-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2010-04-07 | |
| A078414-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2010-04-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078414-001 | AB |
| A078414-002 | AB |
| A078414-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078414-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | AB | 2010-04-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078414-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | AB | 2010-04-07 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078414-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | AB | 2010-04-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078414-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078414-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078414-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | 1080fcea-a5da-499d-a855-690c13559071 | 2026-07-17 | Warnings, Adverse reactions | 078414 ANDA078414 72789-260 72789-261 72789-262 |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | 6f20efca-943b-4bc2-a157-0931bd4d4585 | 2026-03-28 | Warnings, Adverse reactions | 078414 ANDA078414 69584-023 69584-022 69584-021 |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | ea9f44a1-96cf-496a-8c07-18d8de27e512 | 2026-02-25 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 49104797-8202-1376-e063-6294a90adb38 | 2026-01-23 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 47e494d2-8971-3f8f-e063-6394a90adb20 | 2026-01-08 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Proficient Rx LP | 6313edc5-d2d5-44a1-a06f-7f7829c870d2 | 2025-02-01 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 1871ddaf-ed2c-c3ce-e063-6394a90a1bee | 2024-12-20 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | NuCare Pharmaceuticals,Inc. | ffe96aa1-db66-33e4-e053-6394a90a7e4e | 2024-03-26 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 2.5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 132c078d-7d31-a6f2-e063-6294a90af095 | 2024-03-08 | Warnings, Adverse reactions | 078414 ANDA078414 |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | b597d1e1-aba1-4272-bed7-4c95e8150d58 | 2023-04-19 | Warnings, Adverse reactions | 078414 ANDA078414 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0603-2108 | Amlodipine Besylate | amlodipine besylate | Par Pharmaceutical | ANDA | Current |
| 0603-2109 | Amlodipine Besylate | amlodipine besylate | Par Pharmaceutical | ANDA | Current |
| 0603-2110 | Amlodipine Besylate | amlodipine besylate | Par Pharmaceutical | ANDA | Current |
| 43353-684 | Amlodipine Besylate | amlodipine besylate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 43353-691 | Amlodipine Besylate | amlodipine besylate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 48433-308 | Amlodipine Besylate | amlodipine besylate | Safecor Health, LLC | ANDA | Current |
| 50090-1021 | Amlodipine Besylate | amlodipine besylate | A-S Medication Solutions | ANDA | Current |
| 53808-1029 | Amlodipine Besylate | amlodipine besylate | State of Florida DOH Central Pharmacy | ANDA | Current |
| 55700-015 | Amlodipine Besylate | amlodipine besylate | Lake Erie Medical DBA Quality Care Products LLC | ANDA | Current |
| 61919-460 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | DIRECT RX | ANDA | Current |
| 61919-460 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | DIRECT RX | ANDA | Current |
| 63187-143 | Amlodipine Besylate | amlodipine besylate | Proficient Rx LP | ANDA | Current |
| 68788-1737 | Amlodipine Besylate | amlodipine besylate | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 68788-1738 | Amlodipine Besylate | amlodipine besylate | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 69584-021 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-021 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-022 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-022 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-023 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 69584-023 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Oxford Pharmaceuticals, LLC | ANDA | Current |
| 70518-0812 | Amlodipine Besylate | amlodipine besylate | REMEDYREPACK INC. | ANDA | Current |
| 72789-260 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-260 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-260 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-261 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-261 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-261 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-262 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-262 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 72789-262 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |